Grandbrothers/iStock Editorial via Getty Images National Institutes of Health outlays increased by about 5% in June 2024 Y/Y to $4.218B, according to Baird Equity Research. The June outlays grew 4% vs May end, while CY2Q24 outlays increased about 9% YY.
The report said that while Baird hasn’t observed a precise correlation between NIH outlays and quarterly academic/government results, they nonetheless view consistent increases as thematically positive. Baird estimates NIH exposure for tools names as follows: ( NASDAQ: ILMN ) ~15%-20%, ( TECH ) ~15%, ( NYSE: QGEN ) ~6%-7%, ( NYSE: TMO ) ~5%, ( NYSE: AVTR ) ~5%, ( NYSE: RVTY ) ~3%, ( NYSE: A ) ~1%-2%, ( NYSE: WAT ) ~1%, ( DHR ) ~1%, ( NYSE: MTD ) ~1%..